Example searches

ILMN Illumina, Inc.

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Company profile

Ticker
ILMN
Exchange
NASDAQ
Website
www.illumina.com
CEO
Francis A. deSouza
Employees
Incorporated in
Delaware
Location
California
Fiscal year end
Jan 03
Sector
Health Technology > Biotechnology
Industry (SEC)
Laboratory Analytical Instruments
Avantor • Agilent • Perkinelmer • Bio-Rad Laboratories • Waters • Mettler-Toledo International • Bruker • Coherent • Pacific Biosciences of California • Harvard Bioscience ...
Former names
Illumina Inc
SEC CIK
0001110803
Corporate docs
IRS number
330804655

ILMN stock data

(
)

Calendar

1 May 20
11 Jul 20
3 Jan 21

News

Company financial data Financial data

Chart ILMN financial data
Quarter (USD) Mar 20 Dec 19 Sep 19 Jun 19
Revenue 859M 953M 907M 838M
Net income 173M 239M 234M 293M
Diluted EPS 1.17 1.61 1.58 1.99
Net profit margin 20.14% 25.08% 25.80% 34.96%
Operating income 189M 268M 308M 205M
Net change in cash -51M 227M -128M -327M
Cash on hand 1.99B 2.04B 1.82B 1.94B
Cost of revenue 240M 290M 259M 265M
Annual (USD) Jan 17 Jan 16 Jan 12 Jan 11
Revenue 2.4B 2.22B 1.06B 902.74M
Net income 428M 458M 86.63M 124.89M
Diluted EPS 3.07 3.1 0.62 0.87
Net profit margin 17.85% 20.63% 8.21% 13.83%
Operating income 587M 613M 199.46M 211.65M
Net change in cash -34M 466.02M 54.03M
Cash on hand 735M 769M 302.98M 248.95M
Cost of revenue 732M 671M 346.44M 301.2M

Financial data from Illumina earnings reports

Recent insider trades

ILMN insider ownership history Insider history
Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
7 Jul 20 Jay T Flatley Common Stock Sell Dispose S Yes 370.22 4,000 1.48M 230,933
6 Jul 20 Alexander Aravanis Common Stock Grant Aquire A No 0 3,295 0 3,295
6 Jul 20 Alexander Aravanis Performance Shares Common Stock Grant Aquire A No 0 9,885 0 9,885
6 Jul 20 Tousi Susan H Common Stock Sell Dispose S Yes 375 300 112.5K 46,854
5 Jul 20 Francis A deSouza Common Stock Payment of exercise Dispose F No 379.39 336 127.48K 77,822
1 Jul 20 Charles Dadswell Common Stock Sell Dispose S Yes 369.26 121 44.68K 8,034
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2020

ILMN institutional ownership history Ownership history
89.8% owned by funds/institutions
13F holders
 Current Prev Q Change
Total holders 813 876 -7.2%
Opened positions 72 129 -44.2%
Closed positions 135 64 +110.9%
Increased positions 311 303 +2.6%
Reduced positions 316 302 +4.6%
13F shares
 Current Prev Q Change
Total value 390.75B 270.14B +44.6%
Total shares 132.06M 135.67M -2.7%
Total puts 1.41M 1.77M -20.2%
Total calls 1.29M 2.28M -43.2%
Total put/call ratio 1.1 0.8 +40.6%
Largest owners
 Shares Value Change
Baillie Gifford & Co 17.62M $4.81B -0.7%
Vanguard 11.75M $3.21B +2.5%
BLK BlackRock 10.95M $2.99B -1.6%
STT State Street 6.09M $1.66B -1.2%
Edgewood Management 4.86M $1.33B +1.7%
Capital Research Global Investors 4.21M $1.15B -47.2%
Sands Capital Management 3.26M $891.18M -4.9%
MS Morgan Stanley 2.91M $795.55M -20.4%
BK Bank Of New York Mellon 2.62M $714.9M +129.6%
Geode Capital Management 2.43M $663.38M +1.9%
Largest transactions
 Shares Bought/sold Change
Capital Research Global Investors 4.21M -3.77M -47.2%
Jennison Associates 1.76M -2.26M -56.3%
Norges Bank 0 -1.95M EXIT
BK Bank Of New York Mellon 2.62M +1.48M +129.6%
Loomis Sayles & Co L P 1.17M +1.17M NEW
Generation Investment Management 1.68M +1.09M +186.2%
MS Morgan Stanley 2.91M -748.44K -20.4%
Harding Loevner 1.16M +729.54K +170.1%
Select Equity 685.62K +613.2K +846.8%
Lone Pine Capital 0 -519.81K EXIT
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Thermo Fisher Scientific • BGI • Ceres • Roche Holding • Solexa • Luminex • Biocept • Agilent • Third Wave • CareDx
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: accelerated, alter, anniversary, cancel, canceled, certainty, Certification, chain, charged, check, Chinese, claim, conduct, consummated, cumulative, curtailed, decline, degree, deSouza, diagnostic, disrupt, document, duly, duration, electronically, environment, Exhibit, experienced, extent, extreme, filer, formatted, found, impede, Index, industry, Inline, instance, Interactive, invocation, large, mark, moved, movement, negative, negatively, Page, pandemic, par, people, platform, postpone, postponed, Quantitative, registered, registrant, remotely, Renminbi, rest, Reverse, revised, Rule, sam, samad, section, shell, shipping, shorter, size, smaller, spread, superseded, temporarily, thereunto, transition, unable, uncollectible, undersigned, Washington, XBRL, Yuan
Removed: abatement, absolute, absorb, acceptance, accepting, accurate, allocate, allocating, antitrust, apply, area, began, borrowing, broaden, capitalized, carry, classification, closing, CODM, collected, combined, competition, consistent, construction, continuously, coupled, criteria, customary, delivered, derecognized, destination, determining, direct, disclose, distinct, distributor, earned, effectively, enhancing, estate, evenly, exclude, exercised, extension, feet, genome, geographic, good, grow, headcount, hold, identifying, implicit, incremental, influence, initially, investee, invoice, Invoicing, issuer, lab, lag, landlord, lease, leased, LLC, long, Maker, making, met, minimum, NovaSeq, obtain, offer, office, owed, package, perfect, practical, present, privately, proportion, qualify, ranging, real, receipt, receive, recognition, recognize, recognizing, recommendation, redeemable, reduce, regulatory, reimbursed, rendered, rent, rental, repay, require, rolling, satisfaction, scalable, separate, separately, set, shipment, square, standalone, sublease, superior, tenant, title, Topic, transfer, transferred, typically, utility, view, withdrawal
From filing 10-Q 2020 Q1

Financial reports

View all
10-Q
2020 Q1
Quarterly report
1 May 20
10-K
2019 FY
Annual report
11 Feb 20
10-Q
2019 Q3
Quarterly report
25 Oct 19
10-Q
2019 Q2
Quarterly report
31 Jul 19
10-Q
2019 Q1
Quarterly report
26 Apr 19
10-K
2018 FY
Annual report
12 Feb 19
10-Q
2018 Q3
Quarterly report
23 Oct 18
10-Q
2018 Q2
Quarterly report
31 Jul 18
10-Q
2018 Q1
Quarterly report
25 Apr 18
10-K
2017 FY
Annual report
13 Feb 18

Current reports

View all
8-K
Submission of Matters to a Vote of Security Holders
1 Jun 20
8-K
Departure of Directors or Certain Officers
12 May 20
8-K
Illumina Reports Financial Results for First Quarter of Fiscal Year 2020
30 Apr 20
8-K
Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020
14 Apr 20
8-K
Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
6 Feb 20
8-K
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
29 Jan 20
8-K
Results of Operations and Financial Condition
16 Jan 20
8-K
Illumina and Pacific Biosciences Announce Termination of Merger Agreement
2 Jan 20
8-K
Other Events
18 Dec 19
8-K
Departure of Directors or Certain Officers
29 Nov 19

Registration and prospectus

View all
S-8
Registration of securities for employees
7 Aug 15
S-8
Registration of securities for employees
2 Aug 13
S-8
Registration of securities for employees
19 Apr 13
SC TO-T/A
Third party tender offer statement (amended)
23 Apr 12
SC 14D9/A
Tender offer solicitation (amended)
18 Apr 12
SC TO-T/A
Third party tender offer statement (amended)
18 Apr 12
SC TO-T/A
Third party tender offer statement (amended)
12 Apr 12
SC TO-T/A
Third party tender offer statement (amended)
11 Apr 12
SC 14D9/A
Tender offer solicitation (amended)
10 Apr 12
SC 14D9/A
Tender offer solicitation (amended)
9 Apr 12

Proxies

View all
DEFA14A
Additional proxy soliciting materials
16 Apr 20
DEF 14A
Definitive proxy
16 Apr 20
DEFA14A
Additional proxy soliciting materials
24 May 19
DEFA14A
Additional proxy soliciting materials
16 Apr 19
DEF 14A
Definitive proxy
16 Apr 19
PRE 14A
Preliminary proxy
25 Mar 19
DFAN14A
Additional proxy materials by non-management
5 Nov 18
DFAN14A
Additional proxy materials by non-management
2 Nov 18
DEF 14A
Definitive proxy
6 Apr 18
DEFA14A
Additional proxy soliciting materials
6 Apr 18

Other

View all
SD
Conflict minerals disclosure
21 May 20
SD
Conflict minerals disclosure
14 May 19
SD
Conflict minerals disclosure
30 May 18
CT ORDER
Confidential treatment order
9 Mar 18
SD
Conflict minerals disclosure
5 Jun 17
NO ACT
No action letter
25 Jan 17
SD
Conflict minerals disclosure
25 May 16
NO ACT
No action letter
18 Mar 16
CT ORDER
Confidential treatment order
24 Aug 15
SD
Conflict minerals disclosure
29 May 15

Ownership

View all
4
ILLUMINA / JAY T FLATLEY ownership change
8 Jul 20
4
ILLUMINA / Alexander Aravanis ownership change
8 Jul 20
4
ILLUMINA / SUSAN H TOUSI ownership change
8 Jul 20
4
ILLUMINA / Francis A deSouza ownership change
7 Jul 20
4
ILLUMINA / Oene Mark Van ownership change
6 Jul 20
4
ILLUMINA / Francis A deSouza ownership change
6 Jul 20
4
ILLUMINA / Charles Dadswell ownership change
6 Jul 20
4
ILLUMINA / JAY T FLATLEY ownership change
17 Jun 20
4
ILLUMINA / ROBERT P RAGUSA ownership change
17 Jun 20
4
ILLUMINA / Aimee L Hoyt ownership change
10 Jun 20

Patents

View all
APP
Utility
Spatial Indexing of Genetic Material and Library Preparation Using Hydrogel Beads and Flow Cells
9 Jul 20
Implementations of a method for seeding sequence libraries on a surface of a sequencing flow cell that allow for spatial segregation of the libraries on the surface are provided.
APP
Utility
Fluid Management System and Method
9 Jul 20
A fluid detection system includes a wicking material to draw fluid away from a first location with space limitations and proximate to a fluid device or a fluid interface.
APP
Utility
Flow Cell Liquid Degassing System and Method
9 Jul 20
A system utilizes a flow cell for holding an analyte of interest for examination, such as a genetic material to be imaged for sequencing.
APP
Utility
Pattern Angle Spatial Selection Structured Illumination Imaging
9 Jul 20
The disclosure provides for structured illumination microscopy (SIM) imaging systems.
APP
Utility
Multi-Arm Structured Illumination Imaging
9 Jul 20
The disclosure provides for structured illumination microscopy (SIM) imaging systems.